Erratum to: Breast Cancer Res Treat (2013) 142:283–296 DOI 10.1007/s10549-013-2722-8
In the original publication of the article, the blot corresponding to the total P38 protein content for the conditions siCtl and siBRCA1 in Fig. 7a was incorrectly laid out. The corrected Fig. 7a is given in this erratum.
p38 pathway is involved in BRCA1-induced GR activity. a Representative immunoblot for BRCA1, GR P-Ser211, total GR, phospho-MAPK p38, and total MAPK p38 from MCF-7 cells silenced or overexpressing BRCA1. Cells were treated with 100 nM DEX in combination or not with 10 μg/ml SB 202190, a p38 inhibitor. b Potential mechanism as BRCA1 regulates GR expression and activity
Author information
Authors and Affiliations
Consortia
Corresponding authors
Additional information
The online version of the original article can be found under doi: 10.1007/s10549-013-2722-8.
Rights and permissions
About this article
Cite this article
Vilasco, M., Communal, L., Hugon-Rodin, J. et al. Erratum to: Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. Breast Cancer Res Treat 156, 401–402 (2016). https://doi.org/10.1007/s10549-016-3712-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-016-3712-4